TETRAGENEX PHARMACEUTICALS, INC.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Signs
● 1 severe● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 16, 2010
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2010
- NT 10-Qmissed a reporting deadline ↗May 16, 2008
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2008
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Unregistered equity sale · Amended charter or bylawsJan 21, 2011
- Bankruptcy or receivershipNov 1, 2010
- Entered a material agreementJan 20, 2010
- Bankruptcy or receivershipNov 10, 2009
- Debt acceleration / triggering eventApr 28, 2009
- Entered a material agreement · Unregistered equity sale · Other material eventMay 31, 2007
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- REVOKEDJan 16, 2014
- SC 13G/AFINAL AMENDMENT TO SCHEDULE 13GFeb 11, 2011
- 8-KTETRAGENEX PHARMACEUTICALS, INC. FORM 8-K JANUARY 20, 2011Jan 21, 2011
- 10-QTETRAGENEX PHARMACEUTICALS, INC. FORM 10-Q SEPTEMBER 30, 2010Nov 19, 2010
- NT 10-QTETRAGENEX PHARMACEUTICALS, INC. FORM NT 10-Q (12B-25) SEPTEMBER 30, 2010Nov 16, 2010
- 8-KTETRAGENEX PHARMACEUTICALS, INC. FORM 8-KNov 1, 2010
- 10-Q/ATETRAGENEX PHARMACEUTICALS, INC. FORM 10-Q/A JUNE 30, 2010Sep 28, 2010
- 10-QTETRAGENEX PHARMACEUTICALS, INC. FORM 10-Q JUNE 30, 2010Aug 16, 2010
- SC 13DHARVEY KOHN SCHEDULE 13D TETRAGENEX PHARMACEUTICALS, INC.Jun 7, 2010
- 10-QTETRAGENEX PHARMACEUTICALS, INC. FORM 10-Q MARCH 31, 2010May 13, 2010
- 10-KTETRAGENEX PHARMACEUTICALS, INC. FORM 10-K DECEMBER 31, 2009Apr 15, 2010
- NT 10-KTETRAGENEX PHARMACEUTICALS, INC. FORM NT 10-K DECEMBER 31, 2009Mar 31, 2010
- SC 13GSCHEDULE 13GFeb 12, 2010
- 8-KTETRAGENEX PHARMACEUTICALS, INC. FORM 8-K JANUARY 19, 2010Jan 20, 2010
- 10-QTETRAGENEX PHARMACEUTICALS, INC. FORM 10-Q SEPTEMBER 30, 2009Nov 16, 2009
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.